Transplantation immunobiology. An update.
Transplantation of allografts is hampered by immunologic destruction. Alloantigens are recognized directly as intact molecules expressed on the graft or indirectly as allopeptides following processing and presentation by antigen presenting cells. This article describes new information regarding the immune response to alloantigens.
Stepkowski
S M
SM
Department of Surgery, University of Texas Medical School at Houston.
D000818:Animals; D017951:Antigen Presentation / Q000276:immunology; D001402:B-Lymphocytes / Q000276:immunology; D015815:Cell Adhesion Molecules / Q000276:immunology; D016207:Cytokines / Q000276:immunology; D006801:Humans; D007108:Immune Tolerance; D007519:Isoantigens / Q000235:genetics / Q000276:immunology; D008213:Lymphocyte Activation / Q000276:immunology; D008285:Major Histocompatibility Complex / Q000235:genetics / Q000276:immunology; D051379:Mice; D015778:Minor Histocompatibility Antigens / Q000235:genetics / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D014181:Transplantation Immunology / Q000235:genetics / Q000276:immunology*
D015815:Cell Adhesion Molecules; D016207:Cytokines; D007519:Isoantigens; D015778:Minor Histocompatibility Antigens